Ortivus AB ser. A (ORTI-A) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Ortivus AB ser. A (ORTI-A) has a cash flow conversion efficiency ratio of -0.529x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-11.86 Million ≈ $-1.28 Million USD) by net assets (Skr22.41 Million ≈ $2.41 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Ortivus AB ser. A - Cash Flow Conversion Efficiency Trend (2003–2025)
This chart illustrates how Ortivus AB ser. A's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read ORTI-A total liabilities for a breakdown of total debt and financial obligations.
Ortivus AB ser. A Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Ortivus AB ser. A ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Mitra Komunikasi Nusantara Tbk PT
JK:MKNT
|
-0.463x |
|
Inspiration Healthcare Group PLC
LSE:IHC
|
0.222x |
|
Dewhurst plc
LSE:DWHA
|
0.062x |
|
SRAX Inc
NASDAQ:SRAX
|
0.394x |
|
Checkit PLC
LSE:CKT
|
-0.132x |
|
Desarrolladora Homex S.A.B. de C.V
MX:HOMEX
|
-0.024x |
|
GO.D.M Investments Ltd
TA:GODM
|
-0.255x |
|
Works co uk PLC
LSE:WRKS
|
1.780x |
Annual Cash Flow Conversion Efficiency for Ortivus AB ser. A (2003–2025)
The table below shows the annual cash flow conversion efficiency of Ortivus AB ser. A from 2003 to 2025. For the full company profile with market capitalisation and key ratios, see market cap of Ortivus AB ser. A.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | Skr22.41 Million ≈ $2.41 Million |
Skr-25.24 Million ≈ $-2.72 Million |
-1.126x | -182.77% |
| 2024-12-31 | Skr-7.17 Million ≈ $-771.07K |
Skr-9.75 Million ≈ $-1.05 Million |
1.360x | +7869.33% |
| 2023-12-31 | Skr17.30 Million ≈ $1.86 Million |
Skr-303.00K ≈ $-32.61K |
-0.018x | +90.98% |
| 2022-12-31 | Skr35.44 Million ≈ $3.81 Million |
Skr-6.88 Million ≈ $-740.18K |
-0.194x | -173.52% |
| 2021-12-31 | Skr29.44 Million ≈ $3.17 Million |
Skr7.77 Million ≈ $836.61K |
0.264x | -72.11% |
| 2020-12-31 | Skr19.68 Million ≈ $2.12 Million |
Skr18.63 Million ≈ $2.00 Million |
0.947x | +336.12% |
| 2019-12-31 | Skr8.75 Million ≈ $942.07K |
Skr-3.51 Million ≈ $-377.73K |
-0.401x | -71.47% |
| 2018-12-31 | Skr2.18 Million ≈ $234.71K |
Skr-510.00K ≈ $-54.88K |
-0.234x | +69.43% |
| 2017-12-31 | Skr15.55 Million ≈ $1.67 Million |
Skr-11.90 Million ≈ $-1.28 Million |
-0.765x | -180.94% |
| 2016-12-31 | Skr5.22 Million ≈ $561.97K |
Skr4.93 Million ≈ $531.08K |
0.945x | +444.95% |
| 2015-12-31 | Skr12.36 Million ≈ $1.33 Million |
Skr-3.39 Million ≈ $-364.50K |
-0.274x | -116.60% |
| 2014-12-31 | Skr19.35 Million ≈ $2.08 Million |
Skr31.93 Million ≈ $3.44 Million |
1.651x | +498.55% |
| 2013-12-31 | Skr17.21 Million ≈ $1.85 Million |
Skr-7.13 Million ≈ $-767.09K |
-0.414x | -244.38% |
| 2012-12-31 | Skr31.19 Million ≈ $3.36 Million |
Skr8.95 Million ≈ $962.73K |
0.287x | +195.85% |
| 2011-12-31 | Skr29.03 Million ≈ $3.12 Million |
Skr-8.69 Million ≈ $-934.97K |
-0.299x | +24.94% |
| 2010-12-31 | Skr66.95 Million ≈ $7.20 Million |
Skr-26.69 Million ≈ $-2.87 Million |
-0.399x | -235.70% |
| 2009-12-31 | Skr84.63 Million ≈ $9.11 Million |
Skr-10.05 Million ≈ $-1.08 Million |
-0.119x | +33.33% |
| 2008-12-31 | Skr106.52 Million ≈ $11.46 Million |
Skr-18.98 Million ≈ $-2.04 Million |
-0.178x | -1980.44% |
| 2007-12-31 | Skr163.02 Million ≈ $17.54 Million |
Skr-1.40 Million ≈ $-150.23K |
-0.009x | +95.21% |
| 2006-12-31 | Skr226.03 Million ≈ $24.32 Million |
Skr-40.42 Million ≈ $-4.35 Million |
-0.179x | -126.19% |
| 2005-12-31 | Skr229.72 Million ≈ $24.72 Million |
Skr-18.16 Million ≈ $-1.95 Million |
-0.079x | -131.94% |
| 2004-12-31 | Skr224.47 Million ≈ $24.16 Million |
Skr55.57 Million ≈ $5.98 Million |
0.248x | -8.52% |
| 2003-12-31 | Skr225.09 Million ≈ $24.22 Million |
Skr60.91 Million ≈ $6.55 Million |
0.271x | -- |
About Ortivus AB ser. A
Ortivus AB (publ) develops and commercializes medical technology solutions and e-health for healthcare industry in Sweden and internationally. The company offers MobiMed Monitor that monitor and shares vital signs and ECG; MobiMed ePR, an electronic patient record system for documentation of treatment and events; MobiMed enRoute, a navigation, case management, and mass casualty management; MobiMe… Read more